Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
Laurie Davis

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

Laurie Davis, Ph.D.

 Personal Overview

Biographical Sketch Details of Research Personal Overview How to Contact
Laurie Davis
Name:
  Laurie Sue Davis, Ph.D.
Academic Title:
  Associate Professor
Primary Appointment:
  Internal Medicine - Rheumatic Diseases
School:
  Graduate School of Biomedical Sciences
Southwestern Medical School
Degree Program:
  Immunology
Affiliations:
  Simmons Arthritis Research Center
Department Website:
  Rheumatic Diseases Division
Email:
  Laurie Davis, Ph.D.

 PERSONAL OVERVIEW
     
Dr. Davis is currently a member of the Department of Internal Medicine and Harold C. Simmons Arthritis Research Center and faculty of the Immunolgy Graduate Program. The Davis laboratory has focused on the mechanisms regulating T lymphocyte activation and differentiation. The laboratory has also developed an interest in the altered immune responses observed in patients with autoimmune diseases. The laboratory currently has two main areas of investigation. First, they are interested in understanding human CD4+ T cell differentiation and cytokine production. These studies evaluate the influences, such as antigen-presenting cells, that direct T helper cell differentiation. Another goal of these studies is to understand the role of CD4+ T cells in the perpetuation of chronic inflammatory diseases. A second area of investigation involves the search for new markers of human autoimmunity and disease severity. For these studies, both innate and immune subsets of blood cells from patients with autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis are compared to healthy controls by gene expression profiling and extensive phenotyping. These studies will elucidate molecular pathways that are altered by autoimmune diseases and could identify novel therapeutic targets.
 
 INTERESTING LINKS
 
   Department Website: Rheumatic Diseases Division